Skip to main navigation Skip to search Skip to main content

Antipsychotic Medications for Low-Income Preschoolers: Long Duration and Psychotropic Medication Polypharmacy

  • W. David Lohr
  • , Kahir Jawad
  • , Yana Feygin
  • , Jennifer Le
  • , Liza Creel
  • , Natalie Pasquenza
  • , P. Gail Williams
  • , V. Faye Jones
  • , John Myers
  • , Deborah Winders Davis

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

Objective: This study aimed to evaluate prescribing patterns of antipsychotic medication and factors that predict duration of use among low-income, preschool-age children. Methods: State Medicaid claims from 2012 to 2017 were used to identify antipsychotic medication use for children,6 years old. ICD-9 and ICD-10 codes were used to describe child diagnoses. Descriptive and multivariable an-alyses were used to determine patterns of antipsychotic medication use and factors that predicted duration of use. Results: In 2012, 316 children,6 years of age started an antipsychotic medication in a southeastern state. Most were non-Hispanic White (N5202, 64%) and boys (N5231, 73%). Diagnoses included attention-deficit hyperactivity disorder (N5288, 91%), neurodevelopmental disorders (N5208, 66%), anxiety and trauma-related diagnoses (N5202, 64%), and autism spectrum disorders (ASDs) (N5137, 43%). The mean6SD duration of exposure to antipsychotic medication for children in the cohort was 2.661.7 years, but 86 children (27%) had .4 years of exposure. Almost one-third (N597, 31%) received polypharmacy of four or more medication classes, and 42% (N5131) received metabolic screening. Being male, being in foster care, and having a diagnosis of ASD or disruptive mood dysregulation disorder were significantly associated with duration of use of antipsychotic medications; race-ethnicity was not significantly associated with duration of use. Emergency department visits (N5277, 88%) and inpatient hospitalizations (N5107, 34%) were observed during the study period. Conclusions: Many preschoolers received antipsychotic medications for substantial periods. Further research is needed to identify evidence-based practices to reduce medication use and improve outcomes.

Original languageEnglish
Pages (from-to)510-517
Number of pages8
JournalPsychiatric Services
Volume73
Issue number5
DOIs
StatePublished - May 2022

Bibliographical note

Publisher Copyright:
© 2022 American Psychiatric Association. All rights reserved.

Funding

This study was funded, in part, by Norton Children’s Hospital (NCH) and the Kentucky Department for Medicaid Services (DMS) (to Dr. Davis).

Funders
Kentucky Cabinet for Health and Family Services Department for Medicaid Services
Norton Children’s Hospital
Division of Mathematical Sciences

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    ASJC Scopus subject areas

    • Psychiatry and Mental health

    Fingerprint

    Dive into the research topics of 'Antipsychotic Medications for Low-Income Preschoolers: Long Duration and Psychotropic Medication Polypharmacy'. Together they form a unique fingerprint.

    Cite this